Sign up here to receive news updates via email.
-
June 3, 2019 |
Media, Press Releases
BERG Presents Key Findings From Two Important Clinical Initiatives At The 2019 ASCO Annual Meeting: BERG’s Final Phase 1 Results For BPM 31543 In Chemotherapy-Induced Alopecia And A Clinical Study Using BERG’s Interrogative Biology® Platform Demonstrating The Importance Of Altruism In Pancreatic Cancer Biomarker Discovery
read moreBERG Presents Key Findings From Two Important Clinical Initiatives At The 2019 ASCO Annual Meeting NEWS PROVIDED BY BERG Jun 03, 2019, 11:29 ET BOSTON, June 3, 2019 /PRNewswire/ — BERG, a biopharmaceutical company that merges biology with technology to map and identify drivers of diseases, today announced the presentation describing key results from two…
-
March 29, 2019 |
Media, Press Releases
BERG ANNOUNCES DATA PRESENTATIONS AT AACR 2019 DEMONSTRATING EFFICACY OF BPM 31510 IN GLIOBLASTOMA AND IDENTIFICATION OF NOVEL PROSTATE AND PANCREATIC CANCER BIOMARKERS
read moreNEWS PROVIDED BY BERG March 29, 2019 BERG, biopharmaceutical company, that combines biology and technology to elucidate underlying mechanisms of disease, today announced the presentation of 4 posters at the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, being held from March 29th – April 3rd. The poster on BERG’s leading product candidate,…
-
November 7, 2018 |
Media, Press Releases
PRNewswire: BERG Presents Clinical Target Validation Data for the Treatment of Parkinson’s Disease and Novel Mechanism of Action in Neurological Disorders at Neuroscience 2018
read moreBERG Presents Clinical Target Validation Data for the Treatment of Parkinson’s Disease and Novel Mechanism of Action in Neurological Disorders at Neuroscience 2018 NEWS PROVIDED BY BERG Nov 07, 2018, 18:43 ET SHARE THIS ARTICLE BOSTON, Nov. 7, 2018 /PRNewswire/ — BERG LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today…
-
November 2, 2018 |
Media, Press Releases
PRNewswire: Berg Analytics to Present at the AMIA 2018 Annual Symposium
read moreBerg Analytics to Present at the AMIA 2018 Annual Symposium NEWS PROVIDED BY BERG Nov 02, 2018, 07:04 ET BOSTON, Nov. 2, 2018 /PRNewswire/ — Berg Analytics, a division of BERG LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the acceptance of a poster for presentation describing data-driven…
-
October 19, 2018 |
Media, Press Releases
PRNewswire: BERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress
read moreBERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress NEWS PROVIDED BY BERG Oct 19, 2018, 18:49 ET SHARE THIS ARTICLE BOSTON, Oct. 19, 2018 /PRNewswire/ — BERG LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature…
-
June 4, 2018 |
Media, Press Releases
BERG Showcases New Clinical Data on BPM 31510 at ASCO 2018
read moreBERG Showcases New Clinical Data on BPM 31510 at ASCO 2018 NEWS PROVIDED BY BERG Jun 04, 2018, 04:53 ET SHARE THIS ARTICLE BOSTON, June 4, 2018 /PRNewswire/ — BERG, LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today presented in a poster session at the American Society of Clinical…
